Skuldtech, AB Science discover new pancreatic cancer predictive markers
The companies are also planning to use the new markers for future companion test commercialization associated with masitinib, a molecule developed by AB science to treat pancreatic cancer.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.